PTPN5 and Alzheimer disease: We, however, did not detect a similar increase between clinically diagnosed human cohorts, as neither the expression level of STEP61 nor its activity changed significantly in MCI or AD compared to cognitively normal controls (Additional file 1: Fig. S1A).